THE FAST AND THE SUSCEPTIBLE: RAPID DIAGNOSTICS IN INFECTIOUS DISEASE

Similar documents
SIDP Antimicrobial Stewardship Certificate Program Antimicrobial Stewardship and Microbiology: Focus on Rapid Diagnostic Tests

Guidelines for Laboratory Verification of Performance of the FilmArray BCID System

RAPID IDENTIFICATION OF RESISTANCE MECHANISMS

Antimicrobial Stewardship:

ANTIBIOTICS IN THE ER:

OCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA

Rapid Rewards. Identification from Positive Blood Cultures

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

Antimicrobial de-escalation in the ICU

The Role and Effect of Antimicrobial Stewardship Programs Within the Hospital and How Rapid Diagnostics Can Make an Impact

Review of Rapid Diagnostic Tests Used by Antimicrobial Stewardship Programs

Recommendations Regarding Use of Rapid Blood Pathogen Identification Panel Data

Preserving bacterial susceptibility Implementing Antimicrobial Stewardship Programs Debra A. Goff, Pharm.D., FCCP

CONTAGIOUS COMMENTS Department of Epidemiology

The International Collaborative Conference in Clinical Microbiology & Infectious Diseases

Overview of Antimicrobial Stewardship

C&W Three-Year Cumulative Antibiogram January 2013 December 2015

CONTAGIOUS COMMENTS Department of Epidemiology

CARBAPENEM RESISTANT ENTEROBACTERIACEAE (KPC CRE)

10/19/2017. Objectives

2009 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Childrens Hospital

MAGNITUDE OF ANTIMICROBIAL USE. Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges

2010 ANTIBIOGRAM. University of Alberta Hospital and the Stollery Children s Hospital

Appropriate antimicrobial therapy in HAP: What does this mean?

11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

Multi-drug resistant microorganisms

NUOVE IPOTESI e MODELLI di STEWARDSHIP

4/4/2017. Update on Diagnostic Assays for Rapid Detection of Bacteremia. Disclosures. Learning Objectives

Jump Starting Antimicrobial Stewardship

Can we trust the Xpert?

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine

3/10/2016. Faster Microbiology An Outcome Analysis. Disclaimer. Short Topic Objectives

CME/SAM. Validation and Implementation of the GeneXpert MRSA/SA Blood Culture Assay in a Pediatric Setting

Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16

WENDY WILLIAMS, MT(AMT) MSAH DIRECTOR LABORATORY AND PATHOLOGY SERVICES. Appalachian Regional Healthcare System apprhs.org

Antibiotic Stewardship in Nursing Homes SAM GUREVITZ PHARM D, CGP ASSOCIATE PROFESSOR BUTLER UNIVERSITY COLLEGE OF PHARMACY AND HEALTH SCIENCE

9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS

Evaluating the Role of MRSA Nasal Swabs

Linda Taggart MD FRCPC Infectious Diseases Physician Lead Physician, Antimicrobial Stewardship Program St. Michael s Hospital

Aberdeen Hospital. Antibiotic Susceptibility Patterns For Commonly Isolated Organisms For 2015

UCSF guideline for management of suspected hospital-acquired or ventilatoracquired pneumonia in adult patients

4 th and 5 th generation cephalosporins. Naderi HR Associate professor of Infectious Diseases

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

Drive More Efficient Clinical Action by Streamlining the Interpretation of Test Results

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES

Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources

Collecting and Interpreting Stewardship Data: Breakout Session

2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services

Antimicrobial Resistance Strains

Confron'ng An'microbial Resistance: Stewardship and Diagnos'cs

Methicillin-Resistant Staphylococcus aureus Nasal Swabs as a Tool in Antimicrobial Stewardship

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Rapid molecular testing to detect Staphylococcus aureus in positive blood cultures improves patient management. Martin McHugh Clinical Scientist

Antimicrobial stewardship in managing septic patients

2016 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

CONTAGIOUS COMMENTS Department of Epidemiology

ANTIBIOTIC STEWARDSHIP

Comparative Clinical Evaluation of the T2Bacteria Panel versus Blood Culture for the Diagnosis of Bacteremia

Antimicrobial stewardship: Quick, don t just do something! Stand there!

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

Sustaining an Antimicrobial Stewardship

Antimicrobial stewardship

HPN HOSPITALIZED PNEUMONIA APPLICATION

The Rise of Antibiotic Resistance: Is It Too Late?

Understanding the Hospital Antibiogram

Best Practices for Antimicrobial Stewardship Programs. October 25, :00 AM 5:00 PM New Orleans, LA Room:

2017 Antibiogram. Central Zone. Alberta Health Services. including. Red Deer Regional Hospital. St. Mary s Hospital, Camrose

EVIDENCE BASED MEDICINE: ANTIBIOTIC RESISTANCE IN THE ELDERLY CHETHANA KAMATH GERIATRIC MEDICINE WEEK

Educating Clinical and Public Health Laboratories About Antimicrobial Resistance Challenges

Fighting MDR Pathogens in the ICU

6/15/2017 PART 1: THE PROBLEM. Objectives. What is Antimicrobial Resistance? Conflicts of Interest Disclosure Statement

Antimicrobial Mindfulness. Beata Casanas, DO FACP FIDSA Associate Professor Division of Infectious Disease USF Morsani College of Medicine

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

Antibiotic Stewardship in the Hospital Setting

Implementation and Optimization of Antibiotic Stewardship in Acute Care Hospitals: A Clinical Microbiology Laboratory Perspective

Rise of Resistance: From MRSA to CRE

The SUCCESS model for laboratory performance and execution of rapid molecular diagnostics in patients with sepsis

BACTERIAL SUSCEPTIBILITY REPORT: 2016 (January 2016 December 2016)

Enhancement of Antimicrobial Stewardship with TheraDoc Clinical Decision Support Software

Finnzymes Oy. PathoProof Mastitis PCR Assay. Real time PCR based mastitis testing in milk monitoring programs

The Nuts and Bolts of Antibiograms in Long-Term Care Facilities

Concise Antibiogram Toolkit Background

Leveraging the Lab and Microbiology Department to Optimize Stewardship

Antimicrobial Stewardship in the Hospital Setting

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

The Impact of meca Gene Testing and Infectious Diseases Pharmacists. Intervention on the Time to Optimal Antimicrobial Therapy for ACCEPTED

Liofilchem Chromatic Chromogenic culture media for microbial identification and for the screening of antimicrobial resistance mechanisms

Antimicrobial Stewardship Basics Why, What, Who, and How

THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS

LEARNING OBJECTIVES ANTIMICROBIAL USES AND ABUSES INFECTIOUS DISEASE SCARES

Meropenem for all? Midge Asogan ICU Fellow (also ID AT)

New Drugs for Bad Bugs- Statewide Antibiogram

Rapid diagnostics: an AMS tool? Serap Şimşek-Yavuz Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

Antimicrobial Cycling. Donald E Low University of Toronto

SYMMETRY FOAMING HAND SANITIZER with Aloe & Vitamin E Technical Data

11/22/2016. Hospital-acquired Infections Update Disclosures. Outline. No conflicts of interest to disclose. Hot topics:

Antibiotic Stewardship Program (ASP) CHRISTUS SETX

General Approach to Infectious Diseases

Transcription:

THE FAST AND THE SUSCEPTIBLE: RAPID DIAGNOSTICS IN INFECTIOUS DISEASE Brandon Dionne, PharmD, BCPS, AAHIVP Assistant Clinical Professor Northeastern University Clinical Pharmacy Faculty Infectious Diseases Brigham and Women s Hospital

TO OBTAIN CE CREDIT Fill out online evaluation within 7 days of webinar www.mashp.org Click evaluation link on landing page

DISCLOSURES Advisory Board Roche Diagnostics

OBJECTIVES Compare the different types of rapid microbiologic diagnostic tests (RDT) available Explain the utility of RDTs for antimicrobial stewardship efforts Describe the impact of RDTs on patient outcomes

Kumar A, et al. Crit Care Med. 2006;34:1589-1596. Kim SH, et al. Antimicrob. Agents Chemother. 2008;52(1):192-197. Hecker MT, et al. Arch Intern Med 2003;163:972-978. WHY RAPID DIAGNOSTIC TESTING? Time to appropriate antimicrobial therapy has a significant effect on morbidity and mortality Increase in mortality of 7.6% for each hour delay in septic shock Broad spectrum antibiotics may have collateral damage or may not be the most effective agent Vancomycin has been shown to be inferior to β-lactam antibiotics for methicillin-susceptible Staphylococcus aureus (MSSA) Antibiotic use is unnecessary or inappropriate in as many as 30-50% of cases

ANTIMICROBIAL STEWARDSHIP Antimicrobial stewardship programs are multidisciplinary Physician, pharmacist, epidemiologist, clinical microbiologist, infection preventionist, information systems specialist Goals are to improve outcomes and minimize collateral damage Secondary goal to lower costs Prospective audit with feedback is a core strategy Use of RDTs is suggested for respiratory and blood specimens Dellit TH, et al. Clin Infect Dis. 2007;44(2):159-177. Barlam TF, et al. Clin Infect Dis. 2016;62(10):e51-77

ANTIMICROBIAL DEVELOPMENT VS RESISTANCE Total # New Antibacterial Agents 1 = Methicillin-resistant Staphylococcus aureus (MRSA) 2 = Vancomycin-resistant Enterococci (VRE) 3 = Imipenem-resistant Pseudomonas aeruginosa 4 = Imipenem-resistant Acinetobacter baumanii 5 = Fluconazole-resistant Candida spp. Adapted from Septimus EJ, Owens RC. Clin Infect Dis 2011;53:S8-S14.

CURRENT RDTs Currently available RDTs use a variety of methods for detection Differing levels of complexity and turnaround times (TATs) May be able to detect only a single organism or multiple organisms Some can detect antimicrobial resistance May be helpful in targeted therapy and de-escalation

https://blog.caranddriver.com/audi-a3-luxury-car-abstinence-commercial-is-terrible-and-heres-why-the-ad-section/

TIMELINE OF STANDARD DIAGNOSTICS Basic microbiology Culture Gram stain Colony isolation Biochemical tests Identification and susceptibility Goff DA, et al. Pharmacotherapy. 2012;32(8):677 687

https://blog.caranddriver.com/2013-toyota-rav4-baby-translator-commercial-its-a-gas-the-ad-section/

MALDI-TOF MS Matrix-assisted laser desorption ionization time of flight (MALDI-TOF) mass spectrometry (MS) Can identify to either genus or species level Very fast 5 minutes to identification Hardware is expensive Individual tests are inexpensive http://www.sigmaaldrich.com/technical-documents/articles/biology/custom-dna-oligos-qc-analysis-by-mass-spectrometry.html

MALDI-TOF VS CONVENTIONAL METHODS Quasi-experimental study of patients with gram negative bacteremia 46 hour reduction in time to de-escalation (p = 0.004) 36.7 hour improvement in time to effective treatment in patients with inactive therapy (p < 0.001) Reduction in LOS by 2.6 days (p = 0.01) and cost by ~$20,000 (p = 0.009) Quasi-experimental study of patients with bacteremia or candidemia Decrease in time to effective antibiotic therapy (20.4 vs 30.1 hours; p = 0.021) 2.8 day decrease in mean LOS (p = 0.07) Reduction in mortality from 20.3% to 14.5% (p = 0.02) Perez KK, et al. Arch Pathol Lab Med. 2013;137:1247-1254. Huang AM, et al. Clin Infect Dis. 2013;57:1237-1245.

MALDI-TOF MS Advantages Can identify many different bacteria and fungi Not specific to a certain specimen Very easy to set up and quick to run Disadvantages High upfront cost Requires pure colony Lysing kits may allow detection directly from positive blood culture No susceptibility/resistance information

https://blog.caranddriver.com/2014-toyota-corolla-style-never-goes-out-of-style-commercial-and-the-point-is-the-ad-section/3rd-gear-8/

PNA FISH Peptide nuclueic acid fluorescence in situ hybridization Can detect select gram positive, gram negative, and yeasts in 20 minutes Reagents selected based on gram stain Can detect polymicrobial infections

PNA QuickFISH PROCESS http://www.opgen.com/pathogenid/quickfish-products/

YEAST TRAFFIC LIGHT PNA FISH http://www.advandx.com/science/

YEAST PNA FISH VS CONVENTIONAL METHODS Quasi-experimental study of patients with blood cultures positive for yeast Decrease in mean time to targeted therapy from 2.3 to 0.6 days (p = 0.0016) Mean time to species identification of 0.2 vs 4.0 days (p < 0.001) Cost savings of about $415 per patient Quasi-experimental study of patients with blood cultures positive for yeast Decrease in caspofungin DDD from 8.7 to 3.2 in patients with C. albicans (p < 0.05) Decrease in cost of about $1800 per patient $1700 after accounting for cost of PNA FISH Heil EL, et al. Am J Health Syst Pharm. 2012;69:1910-1914. Forrest GN, et al. J Clin Microbiol. 2006;44(9):3381-3383.

S. aureus/cons PNA QuickFISH http://www.advandx.com/wp-content/uploads/2014/07/adv-224-revd-qf-staph-brochure-v5.pdf

S. aureus/cons PNA FISH VS CONVENTIONAL METHODS Prospective, randomized, controlled study of patients with blood cultures positive for gram positive cocci in clusters (GPCC) Reduction in mortality (16.8% vs 7.9%, p = 0.05) Biggest change in ICU mortality (47.8% vs 9.5%, p = 0.01) 2 day decrease in duration of antimicrobial therapy and length of stay (LOS) Retrospective cohort of patients with blood cultures positive for CoNS Use of PNA FISH led to a significant reduction in LOS of 2 days (p < 0.05) Non-significant difference in defined daily doses Reduction in total cost of care by about $4000 per patient Ly T, et al. Ther Clin Risk Manag. 2008;4:637-640. Forrest GN, et.al. J Antimicrob Chemother. 2006;58:154-158.

E. faecalis/oe PNA QuickFISH

E. faecalis/oe PNA QuickFISH VS CONVENTIONAL METHODS Quasi-experimental study of patients with blood cultures positive for gram positive cocci in pairs and chains 3 day reduction in identification of E. faecalis (1.1 vs 4.1 days; p < 0.001) 2.3 day reduction in identification of E. faecium (1.1 vs 3.4 days; p < 0.001) Decreased time to appropriate therapy from 3.1 to 1.3 days (p < 0.001) 26% vs 45% 30-day mortality (p = 0.04) Forrest GN, et al. Antimicrob Agents Chemother. 2008;52:3558-3563.

GNR TRAFFIC LIGHT PNA QuickFISH http://www.opgen.com/pathogenid/quickfish-products/gram-negative-quickfish/

PNA FISH Advantages Relatively inexpensive Quick turnaround directly from positive blood culture Disadvantages More hands-on time for micro lab Limited in number of species that can be detected No susceptibility/resistance data

https://blog.caranddriver.com/2014-chevy-corvette-stingray-commercial-catch-it-if-you-can-the-ad-section/

PCR Polymerase chain reaction (PCR) is a type of nucleic acid amplification test (NAAT) Detects genetic material of pathogen Multiplex PCR (mpcr) can detect multiple organisms and/or resistance mechanisms https://www.thermofisher.com/ng/en/home/life-science/cloning/cloning-learning-center/invitrogen-school-of-molecular-biology/pcr-education/pcr-reagents-enzymes/pcr-cycling-considerations.html

PCR-BASED RDTs FOR DETECTING STAPHYLOCOCCUS Organism Time (h) Technology Batch Pure colony Automated CLIA Complexity Trade Name MRSA 2 PCR Yes No Yes High Roche LightCycler MRSA MSSA, MRSA, CoNS MSSA, MRSA, CoNS 2 Multiplex PCR 1 Multiplex PCR MSSA, MRSA 1 Multiplex PCR Yes No Yes High BD GeneOhm Staph SR No No Yes Moderate Cepheid Xpert MRSA/SA BC No No Yes Moderate Cepheid Xpert MRSA/SA SSTI Adapted from Bauer KA, et al. Clin Infect Dis. 2014;59(S3):S134-5145

XPERT VS CONVENTIONAL METHODS Quasi-experimental study of patients with blood cultures positive for GPCC 55% vs 76% (p < 0.01) of patients without S. aureus bacteremia treated for S. aureus infection 5.2 vs 49.8 hours (p = 0.007) until MRSA treatment switched to MSSA treatment Quasi-experimental study of patients with S. aureus bacteremia Mean reduction in time to MSSA treatment of 1.6 d (p = 0.02) Length of stay reduced by 6.2 days (p = 0.07) Hospital costs reduced by $21,387 (p = 0.02) Parta M, et al. Infect Control Hosp Epidemiol. 2010;31(10):1043-1048. Bauer KA, et al. Clin Infect Dis. 2010;51(9):1074-1080.

MULTIPLEX PCR Hands-on time of 2 minutes and turnaround time of 1-2 hours Two major mpcr platforms available for positive blood cultures Nanosphere Verigene BC-GP detects meca (MRSA) and vana/b (VRE) BC-GN detects CTX-M (extended spectrum beta-lactamase) and IMP, KPC, NDM, OXA, and VIM (carbapenemases) Does not detect yeast BioFire FilmArray BCID detects meca, vana/b, and KPC Detects Candida albicans, C. glabrata, C. krusei, C. parapsilosis, and C. tropicalis

mpcr FOR GRAM POSITIVES Pathogen FilmArray Verigene Enterococcus E. faecalis E. faecium Staphylococcus S. aureus S. lugdunensis S. epidermidis Streptococcus S. anginosus Group S. agalactiae (Group B) S. pneumoniae S. pyogenes (Group A) Listeria (L. monocytogenes)

mpcr FOR GRAM NEGATIVES Pathogen FilmArray Verigene Acinetobacter (A. baumanii) Pseudomonas aeruginosa Neisseria meningitidis Haemophilus influenzae Enterobacteriaceae Citrobacter Enterobacter (E. cloacae complex) Escherichia coli Klebsiella oxytoca Klebsiella pneumoniae Proteus Serratia marcescens Not FDA-cleared

mpcr VS CONVENTIONAL METHODS Quasi-experimental study of patients with GNR bacteremia Pathogen identification 10.9 h vs 37.9 h (p < 0.001) Reductions in LOS, 30-day mortality, and mortality associated with multidrug-resistant organisms Reduction in time to effective therapy for ESBL-producing organisms Quasi-experimental study of pediatric patients with positive blood cultures Time to optimal therapy of 26.7 vs 60.2 hours (p = 0.001) Time to effective antibiotics reduced from 6.9 to 3.4 hours (p = 0.03) Unnecessary antibiotics for contaminants decreased from 76% to 26% (p < 0.001) Walker T, et al. J Clin Microbiol. 2016;54(7):1789-96. Messacar K, et al. J Pediatric Infect Dis Soc. 2017;6(3):267-274.

VerigeneVS FilmArray 80 positive blood cultures with gram positive isolates were evaluated by conventional identification and susceptibility testing and compared to: Verigene BC-GP 100% agreement FilmArray BCID 85% agreement Missed 2 CoNS and 1 Viridans group Streptococcus Identified 1 MSSA as MRSA and 8 CoNS as CoNS+Enterococcus FilmArray reported 8 meca that Verigene did not TAT for FilmArray was half as long as Verigene Sailey CJ, et al. Abstract #D-106 at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, District of Columbia, United States; September 2014.

FilmArray FOR POLYMICROBIAL INFECTIONS FilmArray BCID panel detects gram positive, gram negative, and yeast pathogens Other RDTs may require multiple panels/reagents for each of these types of organisms FilmArray may be able to detect pathogens which were not evident on preliminary gram stain Case report of a patient found to have GPCCs on gram stain FilmArray uncovered a polymicrobial infection, including gram positive, gram negative, and fungal pathogens Verigene BC-GN likely would not have been run based on gram stain Timbrook T, et al. J Clin Microbiol. In Press.

mpcr Advantages Rapid turnaround with very little hands-on time Detects most common pathogens Provides some resistance information Other syndromic panels available Disadvantages Cost of hardware and panels is higher than many other RDTs Difficult to distinguish active infection from colonization/previous infection Cannot detect pathogens/resistance not included on panel

https://blog.caranddriver.com/the-ads-for-the-dodge-dart-theyre-smart-and-heres-why-the-ad-section/

AUTOMATED FISH/IMAGING Accelerate Pheno PhenoTest BC Combination of automated FISH and morphocellular kinetic analysis Uses fluorescence imaging and growth curve algorithm to predict susceptibility Hands-on time of 2 minutes Turnaround time of 1.33 hours to identification and 6.6 hours to susceptibility 97.4% sensitivity and 99.3% specificity for pathogen identification 95.1% essential agreement and 96.0% categorical agreement for susceptibility Willey BM, et al. Open Forum Infect Dis. 2017; 4(Suppl 1): S594 S595. http://acceleratediagnostics.com/news/accelerate-diagnostics-submits-de-novo-request-fda-accelerate-pheno-system-accelerate-phenotest-bc-kit/

AUTOMATED FISH/IMAGING Advantages Identifies similar number of pathogens to mpcr Not limited to specific resistance genes Most rapid susceptibility with MICs Disadvantages No real world clinical data yet Sensitivity and specificity may change with increased use Cost?

https://www.amazon.com/nos-14760nos-electric-nitrous-bottle/dp/b0006hplyw

MAGNETIC RESONANCE T2Dx T2Candida panel available T2Bacteria (currently research use only in US) Superparamagnetic particles bind pathogen changes in magnetic resonance signal Hands-on time of 2 minutes Identifies C. albicans, C. tropicalis, C. parapsilosis, C. krusei and C. glabrata direct from whole blood in less than 6 hours 99.4% specificity and 91% sensitivity in contrived trial (250 seeded and 50 negative controls) Mylonakis E, et al. Clin Infect Dis. 2015;60(6):892-9.

RDTs IN PATIENTS AT RISK FOR INVASIVE CANDIDIASIS Prospective study with Monte Carlo simulation analysis Average time to identification by conventional methods was 2.2 ± 1.3 days vs Average time to start antifungal therapy was 3.5 days for conventional vs 0.6 days for T2Candida in simulation Negative T2Candida could also be used for discontinuation Aitken SL, et al. Ann Pharmacother. 2014;48(6):683-690.

MAGNETIC RESONANCE Advantages VERY rapid results Low limit of detection Fully automated Disadvantages Cost Clinical data still limited The gold standard reference for sensitivity and specificity is not clear Unclear what to do with positive result but negative blood culture

https://blog.caranddriver.com/mercedes-benz-chicken-magic-body-control-commercial-a-pluckin-rip-off-the-ad-section/

RDTs WITHOUT ASP INTERVENTION Phase I Without pharmacist intervention Phase II With pharmacist intervention Carver PL, et al. J Clin Microbiol. 2008;46:2381-2383.

RDTs WITHOUT ASP INTERVENTION Banerjee R, et al. Clin Infect Dis. 2015;61(7):1071-80.

RDTs WITHOUT ASP INTERVENTION Meta-analysis of 31 trials of molecular RDT on clinical outcomes RDTs associated with decreased mortality Difference was non-significant when implemented without ASP intervention Timbrook TT, et al. Clin Infect Dis. 2017;64(1):15-23.

CHOOSING AND IMPLEMENTING AN RDT Prevalence and/or burden of pathogen Cost of device and test May need to work with lab to justify costs through other savings to health system Workflow of lab Need to have a plan for notification/intervention!

COMPARISON OF RDTs RDT Specimen Resistance/ Susceptibility Cost Hardware/Test Hands-on Time (mins) MALDI-TOF Pure colony - $$$$/ 2 0.1 PNA FISH Positive BCx - $/$ 5+ 0.33 mpcr Positive BCx + $$/$$ 2 1-2 TAT (hrs) FISH/Imaging Positive BCx ++ $$/$$ (?) 2 1.5/6.5 Magnetic Resonance *Direct from whole blood - $$$/$$$ 2 <6*

CONCLUSION There are a variety of RDTs available with different pros and cons RDTs provide results more quickly than conventional methods Often no difference is seen without active notification and follow-up RDTs may have an even bigger impact as they become more rapid Potential for use in targeted therapy for multidrug-resistant organisms

QUESTION 1 Which of the following provides the fastest turn-around time from time of collection of blood culture to pathogen identification? A. Magnetic resonance B. MALDI-TOF MS C. Multiplex PCR D. FISH/MCA

QUESTION 1 Which of the following provides the fastest turn-around time from time of collection of blood culture to pathogen identification? A. Magnetic resonance B. MALDI-TOF MS C. Multiplex PCR D. FISH/MCA

QUESTION 2 Which of the following rapid diagnostic tests can be used to support de-escalation of empiric MRSA coverage? A. PNA FISH B. MALDI-TOF MS C. Multiplex PCR D. EIA

QUESTION 2 Which of the following rapid diagnostic tests can be used to support de-escalation of empiric MRSA coverage? A. PNA FISH B. MALDI-TOF MS C. Multiplex PCR D. EIA

QUESTION 3 Combining antimicrobial stewardship intervention with rapid diagnostic testing reduces time to appropriate antibiotics more than implementing rapid diagnostic tests alone. A. True B. False

TO OBTAIN CE CREDIT Fill out online evaluation within 7 days of webinar www.mashp.org Click evaluation link on landing page

QUESTIONS?